PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 213 filers reported holding PORTOLA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.72 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $2,388,000 | -19.1% | 100,000 | -9.1% | 0.00% | -25.0% |
Q3 2019 | $2,950,000 | -15.0% | 110,000 | -14.0% | 0.00% | 0.0% |
Q2 2019 | $3,470,000 | +42.9% | 127,900 | +82.7% | 0.00% | +33.3% |
Q1 2019 | $2,429,000 | +112.1% | 70,000 | +197.7% | 0.00% | +200.0% |
Q4 2017 | $1,145,000 | -7.9% | 23,514 | +2.2% | 0.00% | -50.0% |
Q3 2017 | $1,243,000 | +374.4% | 23,014 | +392.7% | 0.00% | – |
Q2 2017 | $262,000 | -77.1% | 4,671 | -84.5% | 0.00% | -100.0% |
Q1 2015 | $1,146,000 | +84.8% | 30,200 | +37.8% | 0.00% | 0.0% |
Q4 2014 | $620,000 | +2.8% | 21,919 | -8.2% | 0.00% | 0.0% |
Q3 2014 | $603,000 | – | 23,869 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fernwood Investment Management, LLC | 228,873 | $7,475,000 | 4.17% |
PFM Health Sciences, LP | 5,326,671 | $173,969,000 | 3.54% |
Marcus Capital, LLC | 22,950 | $750,000 | 2.76% |
Partner Investment Management, L.P. | 72,284 | $2,361,000 | 2.55% |
CADIAN CAPITAL MANAGEMENT, LP | 1,240,944 | $40,529,000 | 2.19% |
HARVEY CAPITAL MANAGEMENT INC | 158,580 | $5,179,000 | 1.94% |
SECTORAL ASSET MANAGEMENT INC | 498,412 | $16,278,000 | 1.78% |
Everett Capital Advisors UK LLP | 551,173 | $18,001,000 | 1.52% |
ROSENBLUM SILVERMAN SUTTON S F INC /CA | 125,210 | $4,089,000 | 1.46% |
Atika Capital Management LLC | 113,000 | $3,691,000 | 1.26% |